SCHEMBL7225660

SCHEMBL7225660

CS(=O)(=O)OC1=C(C(=O)OC(c2ccccc2)c2ccccc2)N2C(=O)[C@@H](NC(=O)C(=NOC(c3ccccc3)(c3ccccc3)c3ccccc3)c3nsc(N)n3)C2SC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 1/20 0.43
▸ NR1I2 O75469 4/20 0.38
▸ PPARG P37231 2/20 0.38
▸ ESR1 P03372 1/20 0.38
▸ PGR P06401 1/20 0.38
▸ HSD17B10 Q99714 5/20 0.38
▸ TDP1 Q9NUW8 4/20 0.38
▸ ALDH1A1 P00352 5/20 0.37
▸ MAPT P10636 5/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ CYP3A4 P08684 3/20 0.37
▸ HPGD P15428 3/20 0.37
▸ SLC15A2 Q16348 2/20 0.37
▸ BLM P54132 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ ADRA1A P35348 1/20 0.37
▸ HTR2B P41595 1/20 0.37
▸ PTGS1 P23219 3/20 0.37
▸ ABCB11 O95342 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6542731 1.00 KCNH2 (0.43) KCNH2NR1I2PPARGESR1PGR
SCHEMBL7225657 1.00 KCNH2 (0.43) KCNH2NR1I2PPARGESR1PGR
SCHEMBL6542726 1.00 KCNH2 (0.43) KCNH2NR1I2PPARGESR1PGR
SCHEMBL6233533 0.91 KCNH2 (0.45) KCNH2NR1I2PPARGESR1PGR
SCHEMBL6238927 0.91 KCNH2 (0.45) KCNH2NR1I2PPARGESR1PGR
SCHEMBL16181564 0.90 HSD17B10 (0.46) KCNH2NR1I2PPARGESR1PGR
SCHEMBL7542677 0.89 NR1I2 (0.51) NR1I2PPARGESR1PGRHSD17B10
SCHEMBL7542672 0.89 NR1I2 (0.51) NR1I2PPARGESR1PGRHSD17B10
SCHEMBL1947682 0.88 KCNH2 (0.43) KCNH2NR1I2PPARGESR1PGR
SCHEMBL2595984 0.88 KCNH2 (0.43) KCNH2NR1I2PPARGESR1PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6599893-B2 Such as (7R)-7-(2-(2-amino-5-chlorothiazol-4-yl)-2-trityl-oxyiminoacetylamino)-3-(4 -methyl-(1,2, 3)thiadiazol-5-ylsulfanyl)-8-oxo-5-thia-1-aza-bicyclo(4.2.0)oct-2-ene-2 -carboxylic acid benzhydryl ester; methicillin-resistance ESSENTIAL THERAPEUTICS, INC. 2003-07-29 — — US disclosed
US-20020115650-A1 Cephalosporin antibiotics and prodrugs thereof MICROCIDE PHARMACEUTICALS. 2002-08-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020115650-A1 Cephalosporin antibiotics and prodrugs thereof PEPD, ABCG2, ABCC1 KCNH2 2498/4885NR1I2 716/4885PPARG 2932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback